967
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Role of NLRP3 inflammasome in Bifidobacterium longum-regulated visceral hypersensitivity of postinfectious irritable bowel syndrome

, &
Pages 1933-1937 | Received 13 Sep 2015, Accepted 13 Oct 2015, Published online: 24 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Susan Westfall, Nikita Lomis & Satya Prakash. (2018) A novel polyphenolic prebiotic and probiotic formulation have synergistic effects on the gut microbiota influencing Drosophila melanogaster physiology. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 441-455.
Read now

Articles from other publishers (12)

Ding Yang, Zixu Wang, Yaoxing Chen, Qingyun Guo & Yulan Dong. (2023) Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis. Computational and Structural Biotechnology Journal 21, pages 2215-2227.
Crossref
Wei Ke, Yongfu Wang, Siyu Huang, Shan Liu, He Zhu, Xiangyu Xie, Huifei Yang, Qin Lu, Jianfeng Gan, Guodong He, Fei Che, Xin Wan & Hongmei Tang. (2022) Paeoniflorin alleviates inflammatory response in IBS-D mouse model via downregulation of the NLRP3 inflammasome pathway with involvement of miR-29a. Heliyon, pages e12312.
Crossref
Ying Xiong, Hong Wei, Chong Chen, Lu Jiao, Juan Zhang, Yonggang Tan & Li Zeng. (2022) Coptisine attenuates post‑infectious IBS via Nrf2‑dependent inhibition of the NLPR3 inflammasome. Molecular Medicine Reports 26:6.
Crossref
Jiaxing Tan, Lingqiu Dong, Zheng Jiang, Li Tan, Xinyao Luo, Gaiqin Pei, Aiya Qin, Zhengxia Zhong, Xiang Liu, Yi Tang & Wei Qin. (2022) Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling. Journal of Translational Medicine 20:1.
Crossref
Zhilei Wang, Yuchen Li, Wenhao Liao, Ju Huang, Yanping Liu, Zhiyong Li & Jianyuan Tang. (2022) Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Mònica Aguilera, Valerio Rossini, Ana Hickey, Donjete Simnica, Fiona Grady, Valeria D. Felice, Amy Moloney, Lauren Pawley, Aine Fanning, Lorraine McCarthy, Siobhan M. O’Mahony, John F. Cryan, Ken Nally, Fergus Shanahan & Silvia Melgar. (2021) Inflammasome Signaling Regulates the Microbial–Neuroimmune Axis and Visceral Pain in Mice. International Journal of Molecular Sciences 22:15, pages 8336.
Crossref
Antonio Berumen, Adam L. Edwinson & Madhusudan Grover. (2021) Post-infection Irritable Bowel Syndrome. Gastroenterology Clinics of North America 50:2, pages 445-461.
Crossref
Swapnil C. Kamble, Farhan F. Shaikh & Joyita Sarkar. 2021. Nanotechnology for Advances in Medical Microbiology. Nanotechnology for Advances in Medical Microbiology 331 347 .
Guanqun Chao & Shuo Zhang. (2020) The characteristics of intestinal flora of IBS‐D with different syndromes. Immunity, Inflammation and Disease 8:4, pages 615-628.
Crossref
Sarah Adriana Scuderi, Giovanna Casili, Marika Lanza, Alessia Filippone, Irene Paterniti, Emanuela Esposito & Michela Campolo. (2020) Modulation of NLRP3 Inflammasome Attenuated Inflammatory Response Associated to Diarrhea-Predominant Irritable Bowel Syndrome. Biomedicines 8:11, pages 519.
Crossref
Kangliang Sheng, Shiman He, Ming Sun, Guanghui Zhang, Xiaowei Kong, Jingmin Wang & Yongzhong Wang. (2020) Synbiotic supplementation containing Bifidobacterium infantis and xylooligosaccharides alleviates dextran sulfate sodium-induced ulcerative colitis . Food & Function 11:5, pages 3964-3974.
Crossref
Hongyun Wei, Linlin Chen, Guanghui Lian, Junwen Yang, Fujun Li, Yiyou Zou, Fanggen Lu & Yani Yin. (2018) Antitumor mechanisms of bifidobacteria (Review). Oncology Letters.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.